INOVIQ Ltd (ASX: IIQ)
Health Care · Health Care Providers & Services · AU
AU$0.16
-8.82% today · -59.7% 1Y
INOVIQ Ltd (ASX: IIQ) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $15.23M and employs 15 people.
Over the last twelve months the share price has lost 59.7%, trading between 0.16 and 0.57.
Tweenvest scores INOVIQ Ltd across four factors: quality 39/100, value 45/100, growth 74/100. Its strongest factor is growth.
IIQ price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $15.23M
- Revenue (TTM)
- $1.53M
- P/E
- —
- EPS
- -0.06
- Dividend yield
- —
- Beta (5Y)
- 1.48
- 52-week high
- AU$0.57
- 52-week low
- AU$0.16
- Avg volume (3M)
- —
- Shares outstanding
- 140.78M
- Employees
- 15
- Next earnings
- —
About INOVIQ Ltd
INOVIQ Ltd specializes in the research, development, and commercialization of diagnostic and exosome-based products, aiming to improve the detection and treatment of cancer and other conditions across Australia and the United States. Its current portfolio includes the hTERT test, an immunocytochemistry assay that serves as a supplementary tool for urine cytology in bladder cancer screening, alongside EXO-NET, designed for the capture and isolation of exosomes from liquid biopsy specimens. The company also boasts a robust diagnostic pipeline, featuring blood tests currently under development for various cancers, including ovarian and breast cancer. Originally incorporated in 1983 and formerly known as BARD1 Life Sciences Limited until its rebranding to INOVIQ Ltd in December 2021, the company maintains its headquarters in Notting Hill, Australia.
- ISIN
- AU0000196149
- Founded
- 2016
- Listed since
- Jan 28, 1988
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Longduoduo Company LimitedOTCPK: LDDD | $15.31M | $— | — |
| Psychemedics CorporationOTCPK: PMDI | $15.25M | $— | — |
| D & M Company Co., Ltd.TSE: 189A | $15.25M | ¥1,042.00 | -5.19% |
| G3 Global BerhadKLSE: G3 | $15.24M | RM0.02 | +50.00% |
| Avem Health Partners, Inc.OTCPK: FPCG | $15.17M | $— | — |
| Syra Health Corp.OTCPK: SYRA | $14.91M | $0.86 | +4.23% |
| Balsm Alofoq Medical CompanySASE: 9620 | $14.65M | SR22.00 | -1.43% |
| IBL HealthCare LimitedKASE: IBLHL | $14.63M | PKRs41.12 | -1.23% |
Figures last refreshed Oct 11, 2026.